The short version of triple agonist fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-05-22 and is reviewed periodically as new material appears.
Clinical development has progressed through phase 2 trials in adults with obesity and type 2 diabetes, with phase 3 programs reported as ongoing. Reported outcomes include reductions in body weight and improvements in glycemic measures over defined treatment periods. Whether these effects translate into durable benefits after treatment ends remains an open question. Long-term safety data across broad populations are not yet complete, and regulatory decisions have not been announced.
Retatrutide is an investigational synthetic peptide engineered to activate three distinct hormone receptors within a single molecule. It targets the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor simultaneously. This triagonist design distinguishes it from earlier incretin-based compounds that act on one or two of these pathways. Structural modifications relative to native gut hormones extend its residence time in circulation. The molecule remains under clinical evaluation and is not approved for any indication.
Clinical studies have reported notable reductions in body weight among participants. Early trials measured safety and explored several dose levels, and later studies tracked body-weight change over months of treatment. Investigators also monitor effects on glycemic markers, liver fat, and blood lipids. Because the compound is still in development, questions about long-term safety, cardiovascular outcomes, and durability after treatment ends remain open.
The three-receptor design places retatrutide in a distinct category relative to older incretin-based therapies. Single agonists target one receptor, and dual agonists target two. Adding a third target broadens the pharmacological footprint and introduces new trade-offs among efficacy, tolerability, and glucose control. How these trade-offs resolve in large trials is a central focus of current research.
Retatrutide is an investigational peptide studied for obesity and type 2 diabetes. It is a single synthetic molecule designed to activate three metabolic receptors simultaneously. The compound belongs to the incretin mimetic family, a group of peptides that imitate gut hormones involved in appetite and glucose control. Its research code is LY3437943, and it remains under clinical study rather than cleared for routine medical use.
| Property | Value | Notes |
|---|---|---|
| Receptor targets | GIP, GLP-1, glucagon | One molecule activates all three pathways |
| Research identifier | LY3437943 | Code used in published trial reports |
| Development stage | Phase 3, reported as ongoing | Not approved by any regulatory agency |
| Route studied | Subcutaneous | Administration form used in clinical trials |
| Studied populations | Adults with obesity or type 2 diabetes | Enrollment criteria vary between trials |
与仅靶向单一受体的同类药物相比，瑞他鲁肽增加胰高血糖素受体成分，理论上可提高能量消耗并改变脂肪分布。临床中观察到的体重变化是否主要来自该额外机制，目前尚无定论。胃肠道反应是该类药物常见不良事件，试验中通过剂量递增和监测进行管理。停药后体重反弹、个体差异和长期耐受性仍需更多数据。
瑞他鲁肽是一种在研合成肽，同时作用于胰高血糖素样肽-1、葡萄糖依赖性促胰岛素多肽和胰高血糖素受体。该分子属于多受体激动剂类别，尚未获得任何监管机构的上市批准。当前临床开发主要针对肥胖和2型糖尿病，研究代号为LY3437943。已确立的信息包括受体靶点和部分中期试验结果；最终疗效、长期安全性和适用人群仍属开放问题。
Human evidence remains limited to controlled studies. A phase 2 trial in adults with obesity reported large, dose-dependent reductions in body weight over 48 weeks, with gastrointestinal events as the most frequently recorded adverse effect. Phase 3 programs designated TRIUMPH, for obesity, and TRANSCEND, for type 2 diabetes, are intended to confirm efficacy and to characterize safety in larger populations. Related studies are examining conditions such as knee osteoarthritis in people with obesity and metabolic liver disease. Open questions include long-term tolerability, effects on lean mass, and what happens after treatment is stopped.
Retatrutide is an investigational synthetic peptide that acts on three receptor targets at once: glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon. It is developed by Eli Lilly and appears in the literature and in trial registries under the code LY3437943. The molecule belongs to a class of engineered peptides designed to resist rapid breakdown and permit infrequent subcutaneous administration. No regulatory agency has approved it for clinical use, and all available human data come from controlled trials rather than from routine practice.
Published information places retatrutide in clinical development rather than on the market as an approved therapy. Early-stage and mid-stage trials have examined tolerability and changes in body weight, and larger studies continue to report results over time. Open questions include the durability of effects after treatment stops, the composition of weight lost, and cardiovascular outcomes over long periods. Statements about definitive benefit should therefore be treated as provisional. Regulatory status varies by jurisdiction and changes as applications are reviewed.
Retatrutide is an investigational synthetic peptide designed to activate three distinct receptor systems within a single molecule. Its pharmacological profile combines activity at the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor. This arrangement places it within a broader class of agents often described as multi-agonists, which contrast with compounds that engage one or two targets. Research interest centers on whether simultaneous signaling produces effects that single-receptor agonists cannot achieve alone. A single molecular entity also simplifies manufacturing and delivery logistics compared with combining separate agents.
Mechanistic proposals link each receptor to a different physiological role. Activation of the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors is associated with reduced appetite, slower gastric emptying, and glucose-dependent insulin release. Glucagon receptor signaling, by contrast, is associated with increased energy expenditure and altered lipid handling, though it can also raise blood glucose. The design intent is to balance these contributions so that weight reduction is enhanced without unacceptable glycemic trade-offs. How well that balance holds across individuals is not fully resolved.
If increased glucagon does not raise blood sugar levels to normal, the adrenal glands release epinephrine. Epinephrine works to also increase gluconeogenesis and glycogenolysis, while also decreasing the use of glucose by organs, protecting the brain's glucose supply. After hypoglycemia has been prolonged, cortisol and growth hormone are released to continue gluconeogenesis and glycogenolysis, while also preventing the use of glucose by other organs. The effects of cortisol and growth hormone are far less effective than epinephrine. In a state of hypoglycemia, the brain also signals a sense of hunger and drives the person to eat, in an attempt to increase glucose.
=== Bacteria === Melatonin is produced by α-proteobacteria and photosynthetic cyanobacteria. There is no report of its occurrence in archaea which indicates that melatonin originated in bacteria most likely to prevent the first cells from the damaging effects of oxygen in the primitive Earth's atmosphere. Novo Nordisk have used genetically modified Escherichia coli to produce melatonin.
== Mechanism of action == Penile erection during sexual stimulation is caused by increased penile blood flow resulting from the relaxation of penile arteries and the smooth muscle of the corpus cavernosum. This response is mediated by the release of nitric oxide (NO) from nerve terminals and endothelial cells, which stimulates the synthesis of cyclic guanosine monophosphate (more commonly known as cyclic GMP or cGMP) in smooth muscle cells. cGMP relaxes smooth muscle and increases blood flow to the corpus cavernosum. The inhibition of phosphodiesterase type 5 (PDE5) enhances erectile function by increasing the amount of cGMP. Tadalafil (and sildenafil and vardenafil) inhibits PDE5. However, because sexual stimulation is required to initiate the local penile release of nitric oxide, tadalafil's inhibition of PDE5 will have no effect without sexual stimulation.
Dairy farming based on the Amul Pattern, with a single marketing cooperative, is India's largest self-sustaining industry and its largest rural employment provider. Implementation of the Amul model has made India the world's largest milk producer. Here small, marginal farmers with a couple or so heads of milch cattle queue up twice daily to pour milk from their small containers into the village union collection points. The milk after processing at the district unions is then marketed by the state cooperative federation nationally under the Amul brand name, India's largest food brand. With the Anand pattern three-fourths of the price paid by the mainly urban consumers goes into the hands of millions of small dairy farmers, who are the owners of the brand and the cooperative. The cooperative hires professionals for their expertise and skills and uses hi-tech research labs and modern processing plants and transport cold-chains, to ensure quality of their produce and value-add to the milk.
Sources: en.wikipedia.org
== Personal life == He is the older of two children of Laura (née Sachtleben) Wittliff and William Albert Wittliff. Wittliff's brother William D. Wittliff was a noted American screenwriter and photographer. Various of Wittliff's and his brother's childhood experiences during World War II were depicted in the film Raggedy Man (1981). While in college, Wittliff was a member of the Kappa Sigma fraternity and a long-time supporter of his adopted UofL chapter, and later received the John G. Tower Distinguished Alumnus Award. He married Theresa H. "Mitzie" Wittliff (née Hano) and had two sons. Later she also became his collaborator as well as his data and business manager of the clinical and quality assurance laboratories. Wittliff is widely known as an Oenophile having served as President of the Kentucky Chapters of the American Wine Society and of the American Institute of Wine & Food. He was also a founding member of the Kentucky Chapter of Confrérie de la Chaîne des Rôtisseurs.
where F is the force applied to the ion, m is the mass of the particle, a is the acceleration, Q is the electric charge, E is the electric field, and v × B is the cross product of the ion's velocity and the magnetic flux density. This differential equation is the classic equation of motion for charged particles. Together with the particle's initial conditions, it completely determines the particle's motion in space and time in terms of m/Q. Thus mass spectrometers could be thought of as "mass-to-charge spectrometers". When presenting data in a mass spectrum, it is common to use the dimensionless m/z, which denotes the dimensionless quantity formed by dividing the mass number of the ion by its charge number. Combining the two previous equations yields:
== Medical uses == Rivastigmine is indicated for the treatment of mild to moderate Alzheimer's dementia, and for mild to moderate Parkinson's disease dementia. Rivastigmine is available in capsules, liquid solution, and patches. Rivastigmine has demonstrated treatment effects on the cognitive (thinking and memory), functional (activities of daily living) and behavioural problems commonly associated with Alzheimer's.
In particular, Maricopa County has been targeted by conspiracy theorists for alleged irregularities in how the county voted in the 2020 presidential election; the county's ballots were audited by Republicans in 2021, finding no such claims of voter fraud. Ahead of the 2023 Philadelphia mayoral election and the Pennsylvania primary election, the account for the Philadelphia City Commissioners was unverified, leading to several verified accounts impersonating the commissioners. On May 22, an account aligned with the QAnon conspiracy theory posted an image generated by artificial intelligence that seemingly depicted an explosion near the Pentagon. The fake image was amplified by the Russian propaganda television network RT and the far-right blog Zero Hedge. A verified account posing as Bloomberg News then posted the claim accompanied by several other verified accounts. The S&P 500 fell sharply as a result of the news before rebounding. Several Indian news outlets, including Zee News and Republic TV, aired false reports about the supposed explosion.
== History == A scientific article published in March 2018 proposed a revision of the anatomical definition of the submucosa. They first saw a non compact tissue which should be submucosa using a technology called endomicroscopy. They hypothesised that the submucosa was not compact as it was previously seen on histological analysis but form a reticular pattern. To confirm their findings, they performed fixed samples of bile duct into a freezing media in order to conserve the shape of the submucosa. They then performed a histological analysis and with several staining techniques, they described the submucosa as a network of collagenous bands separating open, formerly fluid-filled spaces. Theses spaces are bordered by fibroblast-like cells CD34 positive. However, these cells are devoid of ultrastructural features indicative of endothelial differentiation, including pinocytotic vesicles and Weibel-Palade bodies.
Sources: en.wikipedia.org
which circumstances constitute anaerobic exercise (blood flow restricted by contracted muscles, insufficient oxygen and blood borne fuels, particularly isometric exercise, as well as sudden increased intensity) versus aerobic exercise (blood flow unrestricted); anaerobic metabolism (phosphagen system and anaerobic glycolysis — ATP produced without oxygen, regardless of adequate blood flow or not, quickly produces ATP which is useful in high-intensity activity and the beginning of any activity) versus aerobic metabolism (oxidative phosphorylation — ATP produced with oxygen, adequate blood flow required, slow to produce ATP but produces for longer and high yield); the different sources of ATP (phosphagen system, carbohydrate metabolism, lipid metabolism [including ketosis], protein metabolism [including the purine nucleotide cycle], oxidative phosphorylation); how long does each source take to start producing ATP; how long does each source continue to produce ATP; how long does each source take to replenish; how much ATP can each source generate; and which fuel source is primarily used given the intensity of the activity. For example, leisurely-paced walking and fast-paced walking on level ground (no incline) are both aerobic, but fast-paced walking relies on more muscle glycogen because of the higher intensity (which would cause exercise intolerance symptoms in those with muscle glycogenoses that hadn't yet achieved "second wind").
=== South Korea === A member of Parliament refers to a member of the Parliament of South Korea. A total of 253 MPs are elected using the first-past-the-post system from parliamentary constituencies, 30 MPs are elected by proportional compensation, and 17 MPs are elected by mixed member majoritarian. In the Second Republic of Korea or if the Constitution of South Korea is amended as a parliamentary system with bicameralism, only the members of the House of Commons of South Korea are called members of Parliament, while the members of the Senate of South Korea are called senators. The members of provincial legislatures are called members of the Legislative Assembly or MLA. In some provinces, such individuals are called councillors and members of the provincial parliament. Members of the National Assembly enjoy various privileges, including immunity from arrest and immunity for legislative acts, along with high power, allowances, and extensive institutional support such as offices, official vehicles, and drivers. Each lawmaker may employ up to nine butler, whose salaries are fully funded by the state. On this foundation of privileges, political experience, personal networks, and local power bases accumulate, making it easier for children or relatives to enter politics. Although power is not legally inherited, in practice this creates a system in which political influence is passed down within families, resembling a form of aristocratic succession.
To some degree, all cells of endotherms give off heat, especially when body temperature is below a regulatory threshold. However, brown adipose tissue is highly specialized for this non-shivering thermogenesis. First, each cell has a higher number of mitochondria compared to more typical cells. Second, these mitochondria have a higher-than-normal concentration of thermogenin in the inner membrane.
=== Product liability === The US Fire Administration says electronic cigarettes have been combusting and injuring people and surrounding areas. The composition of a cigarette is the cause of this, as the cartridges that contain the liquid mixture are so close to the battery. A research report by the US Fire Administration supports this, stating that, "Unlike mobile phones, some e-cigarette lithium-ion batteries within e-cigarettes offer no protection to stop the coil overheating". Peer-reviewed medical literature has also documented characteristic injury patterns associated with e-cigarette explosions and battery failures. A 2023 retrospective burn center study reported that typical injury locations included the groin region, hands, and face, and that many cases required surgical treatment. Beyond individual case reports, population-level surveillance data have also been used to estimate the frequency of e-cigarette-related injuries. A 2024 analysis of US emergency department surveillance data estimated that there were 3,142 ED-treated ENDS/ENNDS product-related injuries from 2012 to 2022. In response to reports of battery-related fires and explosions, US regulators have issued consumer safety guidance. The US Food and Drug Administration has also issued consumer guidance on reducing battery fire and explosion risks, noting that "vape fires and explosions are dangerous" and providing recommendations on charging, storage, and handling. Since the publication of these early reports, the structure of the e-cigarette market has evolved.
On 18 July, amid the large-scale attack by Bedouin fighters on Suwayda Governorate and reports of them entering Suwayda city, backed by fighters from the neighboring Daraa Governorate and other governorates in Syria, Hikmat al-Hijri reportedly demanded the Syrian government to send a conflict resolution force. Reports later circulated that Syrian government forces were preparing to redeploy in the city of Suwayda, following renewed clashes between Druze factions and Bedouin tribes. While an Israeli government related source said that Israel had agreed to a time-limited entry into Suwayda by Syrian government forces, the Syrian Interior Ministry denied that it was preparing to re-enter the city. On 19 July, the Syrian government declared a ceasefire which was approved by the Druze leadership and Bedouin tribes. They arrived at the city of Suwayda but are having difficulty implementing the ceasefire. Fierce street fighting was documented in the city of Suwayda between Bedouins and Druze. AFP, which had teams on the ground, reported that the Bedouin militants had managed to break through the Druze defenses and penetrate the west of the city. An AFP correspondent in Suwayda reported seeing dozens of houses and cars set on fire, and gunmen setting shops on fire after looting them. On 20 July, clashes were reported after the ceasefire in the towns of Al-Ariqah, Rimah, Hazem and Shahba, after an attack by tribal militias, especially in Al-Ariqah after the entry of tribal fighters with the help of General Security Service.
Sources: en.wikipedia.org
It is a synthetic peptide triagonist that engages GIP, GLP-1, and glucagon receptors. Investigational compounds in this class are studied for metabolic conditions rather than for a single organ system.
No regulatory agency has approved it for any indication. It remains an investigational product studied within controlled clinical trial programs.
A dual agonist engages two receptor targets, typically GIP and GLP-1. A triagonist adds glucagon receptor activity, which is intended to influence energy expenditure alongside appetite and glucose handling.
It is a synthetic peptide classified as a triple receptor agonist. It engages the GLP-1, GIP, and glucagon receptors at once. It is investigated for metabolic and weight-related conditions rather than approved for general use.